|
|
|
|
Vol. 53, Issue 6, 981-990, June 1998
: Evidence for
Intramolecular Signal Transduction
Departments of Cellular and Molecular Physiology (G.G., C.H.B.) and Pharmacology (S.R.M.), Yale University School of Medicine, New Haven, Connecticut 06520-8026, and Department of Psychiatry and Center for Neurobiology and Psychiatry (P.T.W.), University of California, San Francisco, California 94143
| |
Summary |
|---|
|
|
|---|
To investigate the mechanism by which cell surface receptors activate
heterotrimeric G proteins, we applied a scanning mutagenesis approach
to the carboxyl-terminal 40% of
s (residues 236-394) to identify residues that play a role in receptor-mediated activation. We identified four regions of sequence in which mutations significantly impaired receptor-dependent stimulation of cAMP synthesis in
transiently transfected cyc
S49 lymphoma
cells, which lack endogenous
s. Residues at the carboxyl
terminus are likely to be receptor contact sites. Buried residues near
the bound GDP are connected to the carboxyl terminus by an
helix
and may regulate GDP affinity. Residues in two adjacent loops of the
GTPase domain at the interface with the helical domain, one of which
includes a region, switch III, that changes conformation on GTP
binding, are positioned to relay the receptor-initiated signal across
the domain interface to facilitate GDP release. Consistent with this
hypothesis, replacing the helical domain of
s with that
of
i2 in an
s/
i2/
s chimera corrects
the defect in receptor-mediated activation caused by
i2
substitutions on the GTPase side of the interface. Thus, complementary
interactions between residues across the domain interface seem to play
a role in receptor-catalyzed activation.
| |
Introduction |
|---|
|
|
|---|
Heterotrimeric
G proteins transmit hormonal and sensory signals received by cell
surface receptors to effector proteins that produce a wide variety of
cellular responses (Neer, 1995
). The
,
, and
subunits of G
proteins are associated in the inactive GDP-bound form. Receptors
activate G proteins by catalyzing replacement of GDP by GTP on the
subunit, resulting in dissociation of
·GTP from 
, each of
which can transmit signals to effectors. Hydrolysis of GTP by the
subunit regulates the timing of deactivation and reassociation of
with 
. As intermediaries between receptors and effectors, G
proteins play a crucial role in determining the specificity, nature,
and degree of amplification of transmitted signals. For example,
Gs mediates stimulation of adenylyl cyclase by
-adrenergic receptors. However, the molecular determinants that
specify receptor/G protein interactions and the mechanism by which
these interactions lead to G protein activation are not well
understood.
Studies of G protein function can be interpreted in the context of the
x-ray crystal structures of GTP
S-bound (active) (Noel et
al., 1993
; Coleman et al., 1994
) and GDP-bound
(inactive) (Lambright et al., 1994
; Mixon et al.,
1995
)
subunits and of 

heterotrimers (Wall et al., 1995
; Lambright et al., 1996
). The
subunits consist of two domains, a GTPase domain that resembles the
oncogene protein, p21ras, and a helical domain
consisting of
helices and connecting loops. Because the bound
nucleotide is buried in the cleft between these domains,
receptor-mediated nucleotide exchange presumably involves a
conformational change that opens the cleft. Comparison of the
structures of GTP
S-bound and GDP-bound
subunits reveals three
regions in the GTPase domain (switches I-III) that change conformation, which could be involved in the activation process.
All
subunit residues involved in associating with receptors and
with 
, which is required for receptor-mediated activation (Fung,
1983
), have not been identified. X-ray crystal structures of the


complex (Wall et al., 1995
; Lambright et
al., 1996
) showed that two
subunit regions contact the
subunit, the amino-terminal
helix and a region that includes
switches I and II. The functional importance of these regions has been
demonstrated using proteolysis (Navon and Fung, 1987
), mutagenesis
(Miller et al., 1988
; Journot et al., 1991
), and
cross-linking (Garcia-Higuera et al., 1996
). Numerous
genetic and biochemical studies, reviewed by Neer (1995)
, have
implicated the carboxyl-terminal region of the
subunit in
interaction with receptors. However, the locations of these 
and
receptor-interacting residues, which are distant from the domain cleft,
have not revealed the mechanism of receptor-mediated G protein
activation.
We exploited the differences in receptor specificities of
s and
i2, which are
relatively divergent members of the
subunit family, sharing ~40%
amino acid identity, to identify additional
subunit residues that
mediate a response to receptor stimulation. Measurements of
receptor-stimulated guanine nucleotide exchange in reconstituted
phospholipid vesicles have demonstrated that the efficiency with which
the
-adrenergic receptor regulates
i2 is
~10% of that seen for
s (Rubenstein
et al., 1991
). The
s residues that
specify interaction with the
-adrenergic receptor have been
localized to the carboxyl-terminal 40% of
s
by means of an
i2/
s
chimera (Masters et al., 1988
).
By examining a panel of
s mutants in which
clusters of residues were replaced by
i2
homologs or alanines, we identified four regions of sequence that are
specifically required for receptor-mediated activation. Residues at the
extreme carboxyl terminus are the most likely receptor contact
residues. Buried residues near the guanine ring of the bound GDP,
connected to the carboxyl terminus by an
helix, may transmit the
signal from the receptor to modulate GDP affinity. Residues in two
adjacent loops of the GTPase domain at the interface with the helical
domain, one of which includes switch III, are positioned to relay the
receptor-initiated signal across the domain interface to facilitate GDP
release. Consistent with this hypothesis, replacing the helical domain
of
s with that of
i2
in an
s/
i2/
s
chimera corrects the defect in receptor-mediated activation caused by
i2 substitutions on the GTPase side of the interface. Thus, complementary interactions between residues across the
domain interface seem to play a role in receptor-catalyzed activation.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials. The expression vector pcDNA I/Amp was obtained from InVitrogen (Carlsbad, CA). Plasmids used for electroporation were prepared using Qiagen Plasmid Maxi Kits (Santa Clarita, CA). Isoproterenol, 1-methyl-3-isobutylxanthine, cAMP, and ATP were obtained from Sigma Chemical (St. Louis, MO). Dulbecco's modified Eagle's medium, minimal essential medium with Earle's salts, and geneticin were obtained from GIBCO BRL (Grand Island, NY). Horse serum was obtained from Hyclone (Logan, UT). [3H]Adenine was obtained from Amersham (Little Chalfont, UK).
Construction of
subunit mutants and chimeras.
The
s mutant constructs were generated from rat
s cDNA (Jones and Reed, 1987
). Chimeric
subunits were constructed from rat
s cDNA and
mouse
i2 cDNA (Sullivan et al.,
1986
). Subcloning and mutagenesis procedures were verified by
restriction enzyme analysis and DNA sequencing. All
subunit
constructs produced in this study contain an epitope, referred to as
the EE epitope (Grussenmeyer et al., 1985
), which was
generated by mutating
s residues
DYVPSD (189-194) to
EYMPTE and
i2 residues
SDYIPTQ (166-172) to
EEYMPTE (single-letter amino acid
code; mutated residues are underlined). This epitope does not affect
the ability of
s to activate adenylyl cyclase
in response to stimulation by the
-adrenergic receptor (Wilson and
Bourne, 1995
).
s mutant
constructs produced in this study are shown in Figs.
1 and 5. To generate these constructs,
the
s cDNA was subcloned into the expression
vector pcDNA I/Amp as a HindIII fragment. The mutations in
s(1),
s(2),
s(10),
s(11),
s(12),
s(13),
s(14),
s(15),
s(16), and
s(17) were
introduced into the
s cDNA by
oligonucleotide-directed in vitro mutagenesis (Kunkel
et al., 1987
s(3),
s(4),
s(5),
s(6),
s(7),
s(8), and
s(9) were
introduced into the
s cDNA by ligating BamHI fragments from previously generated constructs (Berlot
and Bourne, 1992
s in place of the analogous fragment. To
produce
s(2 + 6),
s(6) was digested with BglII and
EcoRV to yield a fragment containing the
s(6) mutations, which was ligated into
s(2) in place of the analogous fragment to
produce an
s cDNA containing both the
s(2) and
s(6) mutations.
|
s constructs, any effects the mutations might
have on receptor-independent cAMP synthesis were controlled for by
measuring basal cAMP accumulation in response to parallel constructs
(the
sRC versions), in which substitution of
cysteine for the arginine at position 201 (Landis et al.,
1989
sRC versions of the constructs were produced
by ligating BamHI fragments containing the mutations into
sRC in place of the analogous fragment.
An
sis chimera, in which
s residues 62-235 are replaced by the
homologous
i2 residues, was produced from
s and an
is chimera,
in which
s residues 1-235 are replaced by the
homologous
i2 residues. The
i2 cDNA was subcloned into pcDNA I/Amp as an EcoRI fragment. To generate
is, the
s cDNA was digested with BamHI and
the fragment encoding
s residues 236-394 and
the 3' untranslated region of
s was ligated
into
i2 in place of the analogous fragment.
Then,
sis was generated using polymerase chain
reactions that produced DNA fragments with overlapping ends that were
combined subsequently in a fusion polymerase chain reaction (Horton
et al., 1989
sis,
sisRC, was
produced by substituting cysteine for Arg179, which causes constitutive activation of
i2 by inhibiting GTPase activity
(Wong et al., 1991
sisRC was
derived from
isRC, which was generated by
ligating the BamHI
s fragment
encoding
s residues 236-394 and the 3' untranslated region of
s into
i2RC in place of the analogous fragment. To
produce
sisRC,
i2RC
was digested with DraIII to yield a fragment containing the
RC mutation, which was ligated into
sis in
place of the analogous fragment.
To introduce the
s(1),
s(2),
s(6), and
s(2 + 6) mutations into
sisRC and
sis, these
mutations were first subcloned as BamHI fragments into
i2RC and
i2 in place
of the analogous fragments. Digestion of these
i2RC and
i2
constructs with DraIII yielded fragments containing the
s(1),
s(2),
s(6), and
s(2 + 6)
mutations with or without the RC mutation, respectively, which were
ligated into
sispcDNA I/Amp in place of the
analogous fragments to produce
sisRC and
sis constructs, respectively, containing the
desired mutations.
cAMP accumulation assay.
Transient transfections were
performed using a subclone of cyc
S49
lymphoma cells (Bourne et al., 1975
) that stably expresses Simian virus
40 large T antigen. These cells were maintained in Dulbecco's modified
Eagle's medium containing 10% heat-inactivated horse serum and 0.6 mg/ml geneticin. Transient transfection of cells expressing TAg with
vectors containing a Simian virus 40 origin of replication has been
shown to maximize expression levels (Clipstone and Crabtree, 1992
).
Therefore, we used the expression vector, pcDNA I/Amp, which contains a
Simian virus 40 origin of replication, as well as the cytomegalovirus
promoter, to electroporate the cyc
cells.
subunit constructs were introduced into
cyc
cells (2 × 107 cells in 1.0 ml of 20 mM
HEPES-buffered minimal essential medium with Earle's salts without
bicarbonate) by electroporation at room temperature using a GIBCO BRL
Cell-Porator (capacitance setting, 1600 µF; voltage setting, 250 V;
Grand Island, NY). After electroporation, the cells were added to 4.0 ml of Dulbecco's modified Eagle's medium containing 10%
heat-inactivated horse serum in 60-mm tissue culture dishes. At 24 hr
after electroporation, the cells were labeled with 12 µCi/ml
[3H]adenine. Then, 24 hr later, cAMP
accumulation was measured. The cells first were washed in assay medium
(20 mM HEPES-buffered Dulbecco's modified Eagle's medium
without bicarbonate). The cells were transferred to 24-well plates and
incubated at 37° for 30 min in the same medium containing 1 mM concentration of the phosphodiesterase inhibitor
1-methyl-3-isobutylxanthine, with or without the addition of 0.1 mM isoproterenol (a saturating stimulus). During this
incubation, the cells attached to the wells. Reactions were terminated
by aspiration and the immediate addition of 5% trichloroacetic acid plus 1 mM concentration each of ATP and cAMP. Nucleotides
were separated on ion exchange columns (Salomon et al.,
1974| |
Results |
|---|
|
|
|---|
Panel of
s mutant constructs for studying
receptor-mediated activation.
The 159-residue carboxyl-terminal
segment of
s (residues 236-394), which
specifies interaction with the
-adrenergic receptor (Masters
et al., 1988
), contains 59 amino acids that are identical in
the sequence of
i2 and therefore do not
specify interaction with this receptor. We previously demonstrated that
mutations of residues in three adjacent regions of the
subunit
structure, the
2/
4,
3/
5, and
4/
6 loops (Noel et
al., 1993
), disrupt the ability of
s to
activate adenylyl cyclase (Berlot and Bourne, 1992
). Because the
current study of receptor-mediated activation of
s mutants used a cAMP accumulation assay, we
did not test 16 residues in these loops. Of the remaining 84 nonidentical residues, 61 were changed in small clusters to
i2 homologs or to alanines using 15
s mutant constructs (Fig. 1).
Transient transfection assay for receptor-mediated activation of
s.
To test the abilities of mutant
s proteins to be activated by the
-adrenergic receptor, we measured receptor-dependent stimulation of
cAMP synthesis after transient transfection of
cyc
S49 lymphoma cells (Bourne et
al., 1975
), which lack endogenous
s (Harris et al., 1985
). Basal cAMP
levels in cells transfected with 10-90 µg of vector containing
s varied linearly in proportion to the plasmid
dose (Fig. 2A). Stimulation of these
s-transfected cells with the
-adrenergic
agonist isoproterenol produced increased cAMP levels that also
exhibited a linear relationship to the amount of transfected plasmid
(Fig. 2A). We also determined receptor-independent cAMP accumulation by
measuring basal cAMP levels in cells transfected with versions of the
s mutants in which Arg201 is mutated to cysteine. The
s containing this mutation,
sRC, exhibits constitutive activation due to
inhibited GTPase activity (Landis et al., 1989
). As with
s-transfected cells, basal cAMP levels in
cyc
cells transfected with 10-90 µg of
vector containing
sRC varied linearly in
proportion to the plasmid dose (Fig. 2B).
|
sRC mutants using 30 µg of plasmid. At this
plasmid dose, the activities of some of the
sRC mutants were reduced compared with that of
sRC. The expression levels of transiently expressed
s proteins in
cyc
cells were not high enough to be
detected using an immunoblot but could be determined in transiently
transfected HEK 293 cells.
sRC mutants with
reduced activities in cyc
cells had
similarly reduced activities in HEK 293 cells. The activities of these
sRC mutants directly correlated with their expression levels as determined by immunoblotting of HEK 293 cell membranes (data not shown). Because the activities of both
s and
sRC in
cyc
cells were directly proportional to
the amount of transfected plasmid (Fig. 2), it was possible to
normalize the expression levels of these
s and
sRC mutant constructs to that of
s and
sRC by
transfecting with increased amounts of plasmid.
To compare receptor-dependent activation of
s
mutants with that of
s, we identified plasmid
doses for which the activities of the
sRC
mutants were similar to those for 30 µg of the
sRC-containing plasmid (Fig.
3B). At these plasmid doses, we compared
receptor-dependent cAMP accumulation due to the corresponding
s mutants with that for 30 µg of the
s-containing plasmid (Fig. 3A). An assumption underlying this normalization procedure is that the substitutions in
the mutant constructs have similar effects on the expression levels of
s and
sRC. This
assumption is supported by the observation that the basal activity of
sRC is ~10-fold greater than that of
s (Figs. 2 and 3) and the basal activities of
each of the
sRC mutants also are ~10-fold
greater than those of the corresponding
s
mutants (Fig. 3).
|
Receptor-mediated activation of
s mutant
constructs.
Receptor-stimulated cAMP accumulation due to 9 of the
15
s mutant constructs was similar to that of
s (Fig. 3A). The other 6 constructs produced
reduced receptor-dependent increases in cAMP levels and delineated four
regions of sequence containing seven or fewer
s mutations that disrupt the ability of
s to be activated by the
-adrenergic
receptor (Fig. 1). Region 1, defined by
s(1)
and
s(2), contains V247, S250, S252, N254,
M255, I257, and R258. Region 2, defined by
s(6), contains G304, K305, and K307-Y311.
Region 3, defined by
s(11) and
s(12), contains V367, E370, and I372-R374.
Region 4, defined by
s(15), contains R389-E392
and L394.
s(6) in region 2 was poorly expressed
in transiently transfected cells, we established lines of
cyc
cells stably transfected with this
s mutant construct to investigate further the
role of region 2 in receptor-mediated activation. As expected from the
results of the transient transfection assay, the expression levels
obtained in
s(6)-expressing lines, as
determined by immunoblotting, were lower than those in
s-expressing lines. In addition, a defect in
receptor-mediated activation was seen in that isoproterenol-stimulated
adenylyl cyclase activity was reduced relative to that stimulated by
GTP
S (Grishina G and Berlot CH, unpublished observations). Thus, the
mutations in region 2 impair receptor-dependent activation but also
seem to decrease the stability of
s.
Mapping of mutations that block receptor-mediated activation onto
the structure of a heterotrimeric G protein.
Because receptors
interact with 

heterotrimers, we mapped the
s residues in which mutations disrupted
activation by the
-adrenergic receptor onto the x-ray crystal
structure of an
t/
i1 chimera complexed with
t
t (Lambright
et al., 1996
) to visualize their positions in three
dimensions (Fig. 4). The recently solved structure of
s·GTP
S (Sunahara et
al., 1997
) is very similar to the structures of
t·GTP
S (Noel et al., 1993
) and
i1·GTP
S (Coleman et al.,
1994
), indicating that the structure of
t/
i1
t
t is a good model for the Gs heterotrimer.
Structural features unique to
s that are
relevant to the mutations that blocked receptor-mediated activation are
discussed. Some of the mutations that blocked receptor-mediated activation map onto solvent-exposed residues that could potentially interact directly with the receptor, whereas others map onto residues that are buried and are more likely to mediate nucleotide exchange by
propagating conformational changes within
s.
|
4 to the middle of the
4/
3 loop and overlaps
with switch III, which assumes different conformations in the
structures of GTP
S-bound and GDP-bound
subunits (Noel et
al., 1993
G/
4 loop. Residues in the amino-terminal part of
region 1, defined by
s(1), are buried within
the interior of the molecule, making contacts with other residues in
the GTPase domain. In the carboxyl-terminal part of region 1, the side
chains of N254, M255, and R258 in
s(2) are in
close proximity to residues in the helical domain. The residues in
region 2 immediately precede a 12-residue insertion of sequence in
s relative to
t and
i. However, comparison of the structures
of
s·GTP
S (Sunahara et
al., 1997
t·GTP
S (Noel et
al., 1993
i1·GTP
S (Coleman
et al., 1994
subunits.
In the structure of
s·GTP
S (Sunahara
et al., 1997
6/
5 loop and the beginning of
5.
Three of the residues, E370, R373, and R374, are solvent-exposed, whereas two, V367 and I372 (shown in Fig. 4), are buried. V367 contacts
the guanine ring of the bound nucleotide (Sunahara et al.,
1997
t/
i1
t
t
structure (Lambright et al., 1996
t·GTP
S (Noel et
al., 1993
2/
4 loop, whereas in the structures of
s·GTP
S (Sunahara
et al., 1997
i1·GDP·AlF4
·RGS4
(Tesmer et al., 1997
i1
1
2 (Wall et al., 1995
subunit.
Region 4 is linked to region 3 by the
5 helix.
Mutations of buried, but not surface-exposed, residues in region 3 disrupt receptor-mediated activation.
To determine the role of the
buried and surface-exposed residues in region 3, we mutated separately
each class of residues. We found that substitution of the buried
residues with the homologous
i2 residues in
s(16) specifically reduced receptor-mediated increases in cAMP production, whereas substitution of the
surface-exposed residues with alanine residues in
s(17) had no effect (Fig.
5). Therefore, this region does not seem
to be a receptor contact site but instead probably is important for
transmitting the receptor signal to the bound GDP. Of the two residues
mutated in
s(16), V367 is located in the
6/
5 loop, presumably in contact with the GDP, whereas I372 is
near the beginning of
5. Because each of these residues was tested
separately in
s(11) and
s(12), both regions seem to be involved in
responding to receptor stimulation.
|
Defects caused by
i2 substitutions in regions 1 and
2 can be complemented by replacing the helical domain with
i2 residues.
Based on the locations of the region 1 and 2 residues at the interface between the GTPase and helical domains,
we hypothesized that they mediate receptor-dependent activation via
interactions with helical domain residues. Mismatches across the domain
interface between
i2 residues in the GTPase
domain and
s residues in the helical domain
thus would be the cause of the reduced abilities of the region 1 and 2
s mutant constructs to be activated by receptor stimulation. According to this hypothesis, replacing the
helical domain of
s with that of
i2 would be expected to reverse the defect in
receptor-mediated activation caused by the
i2
for
s substitutions in regions 1 and 2. To
test this prediction, we produced an
subunit chimera,
sis, in which
i2
homologs are substituted for
s residues
62-235, extending from the end of
1 to the end of
2 (see Fig.
4). The helical domain of this chimera is composed of
i2 residues, and the GTPase domain contains
s residues.
sis were similar to those of
s, with the exception of an elevation in basal
activity. The expression levels of
sisRC (the
GTPase-inhibited version of
sis) and
sRC in membranes of transiently transfected
HEK 293 cells were similar (data not shown). Receptor-independent cAMP
accumulation due to
sisRC also was similar to
that of
sRC (compare Fig.
6B with Fig. 2B). Stimulation of
sis-transfected cells with isoproterenol
resulted in cAMP levels similar to those in stimulated
s-transfected cells (compare Fig. 6A with Fig.
2A). However, in the absence of
-adrenergic receptor stimulation,
sis produced significantly elevated cAMP levels in transiently transfected cells relative to
s (compare Fig. 6A with Fig. 2A). Adenylyl
cyclase assays on membranes of cyc
cells
stably transfected with
s or
sis confirmed that at equivalent expression
levels, the basal activity of
sis was elevated
relative to that of
s (Grishina G and Berlot
CH, unpublished observations).
|
s mutant constructs,
s(1),
s(2), and
s(6), could be due to mismatches between
s and
i2 residues
across the domain interface, we determined the effects of introducing
the
i2 substitutions of these mutant
constructs into
sis. We also tested the effect of introducing the
s(2) and
s(6) mutations together,
s(2 + 6), in both
s
and
sis. We first identified plasmid doses of the GTPase-inhibited RC versions of these constructs that produced receptor-independent cAMP stimulation in transiently transfected cyc
cells comparable to that of 30 µg
of
sRC and of
sisRC
(Fig. 7B). Immunoblots of membranes from
transiently transfected HEK 293 cells demonstrated that the expression
levels of these constructs correlated with their activities (data not
shown).
|
i2 substitutions at the
domain interface was reversed in the context of
sis (Fig. 7A). The isoproterenol-stimulated activities of
sis(2) and
sis(6) were similar to those of
s and
sis. Thus,
matching
i2 residues across the domain
interface seems to have corrected the decreased
isoproterenol-stimulated activity of
s(2) and
s(6). Combining the
s(2) and
s(6)
substitutions in
s(2 + 6) resulted in a larger
decrease in isoproterenol-stimulated activity than was observed for
s(2) and
s(6),
suggesting that the defects in
s caused by the
two clusters of mutations are additive (compare Fig. 7 with Fig. 3).
However, the isoproterenol-stimulated activity of
sis(2 + 6) was similar to those of
sis(2),
sis(6), and
s. In contrast, as was observed for
s(1), the isoproterenol-stimulated activity of
sis(1) was disrupted. The basal
activities of
sis(2) and
sis(2+6) were not significantly different from
that of
sis (p < 0.05), but they were consistently intermediate between those of
s and
sis, suggesting
that matching
i2 residues across the domain
interface partially corrects the elevated basal activity of
sis.
| |
Discussion |
|---|
|
|
|---|
In the analysis of
s mutants presented
here, we identified four regions of sequence that mediate activation by
the
-adrenergic receptor. Two of these regions, the extreme carboxyl
terminus (region 4) and the
6/
5 loop (region 3), have been
implicated previously in receptor/G protein interactions. However,
current models of receptor-mediated activation based on these regions have not addressed the issue of how the bound GDP is released from its
buried position between the GTPase and helical domains. The effects of
mutations in the two other
s regions
identified in the current study (regions 1 and 2), located in the
4/
3 and
G/
4 loops at the interface between these domains,
suggest that interactions between residues across the domain interface
may play a role in the response to receptor stimulation.
Region 4 (the extreme carboxyl terminus) is the most likely candidate
for being a receptor contact site. This region was not visualized in
the
t/
i1
t
t
structure (Lambright et al., 1996
) and occupies different
positions in the structures of
t·GTP
S (Noel et al., 1993
),
s·GTP
S
(Sunahara et al., 1997
),
i1·GDP·AlF4
·RGS4
(Tesmer et al., 1997
), and
i1
1
2 (Wall et al., 1995
), which could indicate a high degree of mobility. In the structure of
t·GTP
S (Noel et al., 1993
),
this region contacts the
2/
4 loop, which interacts with the
subunit in the heterotrimer structures (Wall et al., 1995
;
Lambright et al., 1996
). Because receptors interact only
with
subunits that are associated with 
(Fung, 1983
), the
carboxyl terminus of the
subunit may be located near the interface
between
2/
4 and the
subunit in the heterotrimer/receptor complex, so that receptors interact with both
and
in this region.
Residues at the extreme carboxyl termini of
subunits are sometimes,
but not always, sufficient to confer receptor specificity (Conklin
et al., 1993
, 1996
; Lee et al., 1995
). For
instance, although both the V2 vasopressin and
2-adrenergic receptors couple to
s, only the V2
vasopressin receptor can stimulate a chimeric
subunit in which the
last five residues of
q are replaced with the
corresponding residues of
s (Conklin et
al., 1996
). Differences in the 
specificities of
subunits and receptors may dictate whether carboxyl-terminal swaps
between
subunits will switch receptor specificities. Also, other
regions of
s, not identified in the current
study, probably are receptor contact sites. For example, synthetic
peptides corresponding to
s residues 354-372 and 384-394, which extend from the
4/
6 loop to the beginning of
5 and from the end of
5 to the
subunit carboxyl terminus, respectively, can mimic the effects of
s on
the
2-adrenergic receptor (Rasenick et
al., 1994
). Our study of
s, using
homologous substitutions, does not rule out these regions as being
receptor contact sites because residues that are identical in
s and
i2 were not
changed. Substitutions of surface-exposed
s
residues with alanine residues would be required to determine whether
they are receptor contact sites. Furthermore, evaluation of
receptor-mediated activation of
s mutants with
substitutions in regions important for adenylyl cyclase activation,
which includes residues in the
4/
6 loop (Berlot and Bourne,
1992
), would require an assay that is independent of adenylyl cyclase
activation.
The results of our study suggest that the role of region 3 (the
6/
5 loop and the amino terminal portion of the
5 helix) in
s is to regulate GDP affinity because
substitutions of buried residues near the GDP, but not of adjacent
solvent-exposed residues, disrupt receptor-mediated activation. GDP
release by
s constructs with these
substitutions is not entirely blocked because receptor-independent activation of adenylyl cyclase by the GTPase-inhibited versions of the
constructs is normal. Of the two region 3 residues in which substitutions decreased receptor-mediated activation, V367, which contacts the guanine ring of the GDP, also is near the helical domain.
However, the importance of this proximity to the helical domain is
unclear because the helical domain residues closest to V367 are
conserved among
subunits and are superimposable on the structures
of
s,
i1, and
t. Substitutions of other buried residues in
this region have been shown to affect guanine nucleotide exchange in
several
subunits. The replacement of serine by alanine at position
366 of
s causes constitutive activation by
increasing GDP release (Iiri et al., 1994
). Also, the
substitution of alanine for cysteine at position 325 of
o decreases affinity for GDP (Thomas et
al., 1993
). A mutagenesis study of
t
(Onrust et al., 1997
) identified two residues in the
6/
5 loop in which mutations reduced receptor-mediated activation,
of which one, T323, corresponds to V367 in
s.
Receptors activate G proteins by promoting GTP binding, which involves
both accelerating GDP release and increasing the relative affinity for
GTP compared with GDP (Florio and Sternweis, 1989
). Our results suggest
that the role of regions 1 and 2 in this process may be to relay
conformational changes initiated by receptor/G protein binding across
the domain interface rather than to specify interaction with the
-adrenergic receptor. Altered contacts between the two domains might
facilitate nucleotide exchange by opening the cleft in which GDP is
buried. This hypothesis is based on our observation that replacing
s residues with
i2
homologs on the GTPase side of the domain interface impairs
receptor-mediated activation of
s, but not of
a chimera,
sis, in which the helical domain
consists of
i2 residues. Thus, matching
i2 residues on both sides of the domain
interface of
s seems to restore
receptor-initiated activation. As is sometimes the case with
second-site suppressors of mutations, substitution of the helical
domain of
i2 for that of
s corrects the defects of the region 1 and 2 mutations but does not, on its own, cause a defect in receptor-mediated
activation.
In support of the concept of communication between regions 1 and 2 and
the helical domain, comparison of the structures of GTP
S-bound and
GDP-bound
subunits (Noel et al., 1993
; Coleman et
al., 1994
; Lambright et al., 1994
; Mixon et
al., 1995
) shows that conformational changes in switch III
(located in region 1) are associated with changes in the positions of
helical domain residues in the
D/
E loop, which it contacts in the
GTP
S-bound form. Although it is not clear how receptor/G protein
interaction might lead to conformational changes in switch III,
communication between switches II and III, which are closer together in
the structures of GTP
S-bound versus GDP-bound
subunits, could be involved. In the structure of
s·GTP
S
(Sunahara et al., 1997
), the side chain of the switch III
residue E259 is hydrogen-bonded to the backbone nitrogen of the switch
II residue R228, and the side chain of the switch II residue R231 is
hydrogen-bonded to the side chain of E268 in the
3 helix, adjacent
to switch III. Substitution of a histidine for R231 in switch II of
s leads to a decrease in receptor-mediated
activation (Iiri et al., 1997
).
Our results also suggest that interdomain interactions may regulate the
basal activity of
s, because the basal
activity of
sis is elevated. From the
experiments presented here, we cannot determine whether the increased
basal activity of
sis is due to increased
nucleotide exchange or decreased GTPase activity. However, because the
helical domain of
s, when expressed on its own
and reconstituted with the GTPase domain of
s,
stimulates GTPase activity and promotes binding of GTP
S (Markby
et al., 1993
), interactions across the interface probably
are important for both aspects of guanine nucleotide handling.
Other studies support the idea that interdomain communication plays a
role in receptor-catalyzed G protein activation. A salt bridge
interaction between D173 in the helical domain and K293 in the GTPase
domain of
s is required for receptor-mediated
activation (Codina and Birnbaumer, 1994
). A mutation within region 1 that substitutes tryptophan for arginine at position 258 in
s, R258W, was found in a patient with
pseudopseudohypoparathyroidism, and biochemical analysis revealed that
although the mutant activated adenylyl cyclase normally in response to
GTP
S, it exhibited attenuated responses to
AlF4
and the
-adrenergic
receptor (Warner DR and Weinstein LS, personal communication). Regions
1 and 2 may be important for receptor-mediated activation of other
subunits as well because a segment of
16 (residues 220-240), which
overlaps with regions 1 and 2, contributes to the specificity of
activation by the C5a receptor (Lee et al., 1995
).
Our study suggests that complementary interactions between
subunit
residues across the interface between the GTPase and helical domains
play a role in facilitating receptor-mediated activation. Biochemical
studies using purified
s mutant proteins with
substitutions in these regions and cell lines that stably express these
s mutants will be required to more fully
understand the nature of these intramolecular interactions and the
mechanism by which receptor-catalyzed conformational changes lead to G
protein activation.
| |
Acknowledgments |
|---|
We thank David Lambright and Paul Sigler for the coordinates of
the
t/
i1 chimera
complexed with
t
t,
Stephen Sprang for the coordinates of
s·GTP
S complexed with the catalytic
domains of adenylyl cyclase, Dennis Warner and Lee Weinstein for
sharing data before publication, and Thomas Hynes, Rolando Medina, and Henry Bourne for helpful discussions and critical reading of the text.
| |
Footnotes |
|---|
Received November 25, 1997; Accepted February 18, 1998
This research was supported by National Institutes of Health Grant GM50369 to C.H.B.
Send reprint requests to: Dr. Catherine H. Berlot, Department of Cellular and Molecular Physiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520-8026. E-mail: cathy_berlot{at}qm.yale.edu
| |
Abbreviations |
|---|
GTP
S, guanosine-5'-O-(3-thio)triphosphate;
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
HEK, human
embryonic kidney.
| |
References |
|---|
|
|
|---|
.
Cell
68:
911-922[Medline].
subunit by aluminum fluoride and GDP but not by GTP
S.
J Biol Chem
269:
29339-29342
1 and the mechanism of GTP hydrolysis.
Science (Washington D C)
265:
1405-1412
to that of Gi
.
Nature (Lond)
363:
274-276[Medline].
and Gs
that alter the fidelity of receptor activation.
Mol Pharmacol
50:
885-890[Abstract].

heterotrimers: analysis by cross-linking and mutagenesis of 
.
J Biol Chem
271:
528-535
mutant.
Proc Natl Acad Sci USA
94:
5656-5661
in patients with gain and loss of endocrine function.
Nature (Lond)
371:
164-168[Medline].
impairs its ability to interact with 
subunits and to activate adenylate cyclase.
J Biol Chem
266:
9009-9015
-subunit of a heterotrimeric G protein.
Nature (Lond)
369:
621-628[Medline].
chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.
Nature (Lond)
340:
692-696[Medline].
16 contribute to the specificity of activation by the C5a receptor.
Mol Pharmacol
47:
218-223[Abstract].
subunit.
Science (Washington D C)
262:
1895-1901
specifies coupling of receptors to stimulation of adenylyl cyclase.
Science (Washington D C)
241:
448-451
chain of Gs.
Nature (Lond)
334:
712-715[Medline].
1 induced by GTP hydrolysis.
Science (Washington D C)
270:
954-960
in subunit interaction.
J Biol Chem
262:
15746-15751
complexed with GTP
S.
Nature (Lond)
366:
654-663[Medline].
binding sites on the
subunit of the retinal G protein transducin.
Science (Washington D C)
275:
381-384
s peptides mimic Gs and evoke high affinity agonist binding to
-adrenergic receptors.
J Biol Chem
269:
21519-21525
-adrenergic receptor among Gs, Gi's and Go: assay using recombinant
subunits in reconstituted phospholipid vesicles.
Biochemistry
30:
10769-10777[Medline].
chains.
Proc Natl Acad Sci USA
83:
6687-6691
.
Science (Washington D C)
278:
1943-1947
-activated Gi
1: stabilization of the transition state for GTP hydrolysis.
Cell
89:
251-261[Medline].
o subunit: mutation of conserved cysteines identifies a subunit contact surface and alters GDP affinity.
Proc Natl Acad Sci USA
90:
10295-10299
1
1
2.
Cell
83:
1047-1058[Medline].
z: effects of palmitoylation and myristoylation on
z signaling.
J Biol Chem
270:
9667-9675
subunits of Gi2 inhibit cyclic AMP accumulation.
Nature (Lond)
351:
63-65[Medline].
This article has been cited by other articles:
![]() |
C. A. Johnston and D. P. Siderovski Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural Insights Mol. Pharmacol., August 1, 2007; 72(2): 219 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Oh, J. A. Song, J. S. Moon, M. J. Moon, J. I. Kim, K. Kim, H. B. Kwon, and J. Y. Seong Membrane-Proximal Region of the Carboxyl Terminus of the Gonadotropin-Releasing Hormone Receptor (GnRHR) Confers Differential Signal Transduction between Mammalian and Nonmammalian GnRHRs Mol. Endocrinol., March 1, 2005; 19(3): 722 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, A. Dickson, and C. A. Doupnik G{beta}{gamma}-activated Inwardly Rectifying K+ (GIRK) Channel Activation Kinetics via G{alpha}i and G{alpha}o-coupled Receptors Are Determined by G{alpha}-specific Interdomain Interactions That Affect GDP Release Rates J. Biol. Chem., July 9, 2004; 279(28): 29787 - 29796. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Yu and M. M. Rasenick Real-Time Visualization of a Fluorescent Galpha s: Dissociation of the Activated G Protein from Plasma Membrane Mol. Pharmacol., February 1, 2002; 61(2): 352 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Weinstein, S. Yu, D. R. Warner, and J. Liu Endocrine Manifestations of Stimulatory G Protein {alpha}-Subunit Mutations and the Role of Genomic Imprinting Endocr. Rev., October 1, 2001; 22(5): 675 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K.C. Ho and Y. H. Wong The Amino Terminus of Galpha z is Required for Receptor Recognition, Whereas its alpha 4/beta 6 Loop Is Essential for Inhibition of Adenylyl Cyclase Mol. Pharmacol., November 1, 2000; 58(5): 993 - 1000. [Abstract] [Full Text] |
||||
![]() |
G. Grishina and C. H. Berlot A Surface-Exposed Region of Gsalpha in Which Substitutions Decrease Receptor-Mediated Activation and Increase Receptor Affinity Mol. Pharmacol., June 1, 2000; 57(6): 1081 - 1092. [Abstract] [Full Text] |
||||
![]() |
L. Oliveira, A.C.M. Paiva, and G. Vriend A low resolution model for the interaction of G proteins with G protein-coupled receptors Protein Eng. Des. Sel., December 1, 1999; 12(12): 1087 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Warner and L. S. Weinstein A mutation in the heterotrimeric stimulatory guanine nucleotide binding protein alpha -subunit with impaired receptor-mediated activation because of elevated GTPase activity PNAS, April 13, 1999; 96(8): 4268 - 4272. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Marin, A. G. Krishna, and T. P. Sakmar Rapid Activation of Transducin by Mutations Distant from the Nucleotide-binding Site. EVIDENCE FOR A MECHANISTIC MODEL OF RECEPTOR-CATALYZED NUCLEOTIDE EXCHANGE BY G PROTEINS J. Biol. Chem., July 13, 2001; 276(29): 27400 - 27405. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Unson, C.-R. Wu, T. P. Sakmar, and R. B. Merrifield Selective Stabilization of the High Affinity Binding Conformation of Glucagon Receptor by the Long Splice Variant of Galpha s J. Biol. Chem., July 7, 2000; 275(28): 21631 - 21638. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Aris, A. Gilchrist, S. Rens-Domiano, C. Meyer, P. J. Schatz, E. A. Dratz, and H. E. Hamm Structural Requirements for the Stabilization of Metarhodopsin II by the C Terminus of the alpha subunit of Transducin J. Biol. Chem., January 19, 2001; 276(4): 2333 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Hughes, H. Zhang, D. E. Logothetis, and C. H. Berlot Visualization of a Functional Galpha q-Green Fluorescent Protein Fusion in Living Cells. ASSOCIATION WITH THE PLASMA MEMBRANE IS DISRUPTED BY MUTATIONAL ACTIVATION AND BY ELIMINATION OF PALMITOYLATION SITES, BUT NOT BY ACTIVATION MEDIATED BY RECEPTORS OR AlF4- J. Biol. Chem., February 2, 2001; 276(6): 4227 - 4235. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Marin, A. G. Krishna, V. Archambault, E. Simuni, W.-Y. Fu, and T. P. Sakmar The Function of Interdomain Interactions in Controlling Nucleotide Exchange Rates in Transducin J. Biol. Chem., June 22, 2001; 276(26): 23873 - 23880. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||